315 related articles for article (PubMed ID: 2588925)
1. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
Chen Y; Zhang YX
Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
[TBL] [Abstract][Full Text] [Related]
2. An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) in human brain tumors.
Kimura T; Budka H; Soler-Federsppiel S
Clin Neuropathol; 1986; 5(1):21-7. PubMed ID: 3512139
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
Collins VP
Acta Cytol; 1984; 28(4):401-6. PubMed ID: 6380182
[TBL] [Abstract][Full Text] [Related]
4. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
Reyaz N; Tayyab M; Khan SA; Siddique T
J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological study on malignant glioma--with special reference to GFAP].
Tajika T; Kubo O; Tajika Y; Toyama T; Himuro H; Inoue N; Sakairi M; Kitamura K
No Shinkei Geka; 1986 Jun; 14(7):831-5. PubMed ID: 3020463
[TBL] [Abstract][Full Text] [Related]
6. Glial fibrillary acidic protein expression in pleomorphic adenoma, chordoma, and astrocytoma. A comparison of three antibodies.
Wittchow R; Landas SK
Arch Pathol Lab Med; 1991 Oct; 115(10):1030-3. PubMed ID: 1654872
[TBL] [Abstract][Full Text] [Related]
7. Vimentin and glial fibrillary acidic protein in human brain tumors.
Yung WK; Luna M; Borit A
J Neurooncol; 1985; 3(1):35-8. PubMed ID: 3889231
[TBL] [Abstract][Full Text] [Related]
8. Identification of gliomas by morphological and immunocytochemical analysis in cell cultures.
Fazekas I; Kerekes E; Hegedús B; Nyáry I
Ideggyogy Sz; 2002 May; 55(5-6):173-9. PubMed ID: 12122877
[TBL] [Abstract][Full Text] [Related]
9. [Cytologic diagnosis of glial tumors of the central nervous system].
Shakunov AN; Triputin ES
Arkh Patol; 1987; 49(1):41-6. PubMed ID: 3827633
[TBL] [Abstract][Full Text] [Related]
10. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
Preusser M; Budka H; Rössler K; Hainfellner JA
Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
[TBL] [Abstract][Full Text] [Related]
11. Astrocytes in brain tumours. Differentiation or trapping?
Escalone Zapata J
Histol Histopathol; 1994 Apr; 9(2):325-32. PubMed ID: 8075493
[TBL] [Abstract][Full Text] [Related]
12. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
[TBL] [Abstract][Full Text] [Related]
13. [Significance of immunohistochemistry for neuro-oncology. VI. Occurrence, localization and distribution of glial fibrillary acid protein (GFAP) in 820 tumors].
Gottschalk J; Szymaś J
Zentralbl Allg Pathol; 1987; 133(4):319-30. PubMed ID: 3425011
[TBL] [Abstract][Full Text] [Related]
14. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
[TBL] [Abstract][Full Text] [Related]
15. Expression of non-glial intermediate filament proteins in gliomas.
Hirato J; Nakazato Y; Ogawa A
Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas.
Hasselblatt M; Paulus W
Acta Neuropathol; 2003 Oct; 106(4):385-8. PubMed ID: 12898159
[TBL] [Abstract][Full Text] [Related]
17. alpha(v)beta(3) Integrin in central nervous system tumors.
Lim M; Guccione S; Haddix T; Sims L; Cheshier S; Chu P; Vogel H; Harsh G
Hum Pathol; 2005 Jun; 36(6):665-9. PubMed ID: 16021573
[TBL] [Abstract][Full Text] [Related]
18. Systematic immunohistochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology.
Ikota H; Kinjo S; Yokoo H; Nakazato Y
Acta Neuropathol; 2006 May; 111(5):475-82. PubMed ID: 16598485
[TBL] [Abstract][Full Text] [Related]
19. Primitive neuroectodermal tumors including the medulloblastoma: glial differentiation signaled by immunoreactivity for GFAP is restricted to the pure desmoplastic medulloblastoma ("arachnoidal sarcoma of the cerebellum").
Herpers MJ; Budka H
Clin Neuropathol; 1985; 4(1):12-8. PubMed ID: 3978900
[TBL] [Abstract][Full Text] [Related]
20. GFAP in brain tumor diagnosis: possibilities and limitations.
Gullotta F; Schindler F; Schmutzler R; Weeks-Seifert A
Pathol Res Pract; 1985 Jul; 180(1):54-60. PubMed ID: 4034433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
